Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

386 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
BRCA1 genomic deletions are major founder mutations in Dutch breast cancer patients.
Petrij-Bosch A, Peelen T, van Vliet M, van Eijk R, Olmer R, Drüsedau M, Hogervorst FB, Hageman S, Arts PJ, Ligtenberg MJ, Meijers-Heijboer H, Klijn JG, Vasen HF, Cornelisse CJ, van 't Veer LJ, Bakker E, van Ommen GJ, Devilee P. Petrij-Bosch A, et al. Among authors: vasen hf. Nat Genet. 1997 Nov;17(3):341-5. doi: 10.1038/ng1197-341. Nat Genet. 1997. PMID: 9354803 Free article.
Screening for BRCA2 mutations in 81 Dutch breast-ovarian cancer families.
Peelen T, van Vliet M, Bosch A, Bignell G, Vasen HF, Klijn JG, Meijers-Heijboer H, Stratton M, van Ommen GJ, Cornelisse CJ, Devilee P. Peelen T, et al. Among authors: vasen hf. Br J Cancer. 2000 Jan;82(1):151-6. doi: 10.1054/bjoc.1999.0892. Br J Cancer. 2000. PMID: 10638982 Free PMC article.
Genetic analysis of a breast-ovarian cancer family, with 7 cases of colorectal cancer linked to BRCA1, fails to support a role for BRCA1 in colorectal tumorigenesis.
Peelen T, de Leeuw W, van Lent K, Morreau H, van Eijk R, van Vliet M, Wijnen J, Ligtenberg M, Ginjaar HB, Zweemer R, Menko F, Fodde R, van Ommen GJ, Vasen HF, Cornelisse CJ, Devilee P. Peelen T, et al. Among authors: vasen hf. Int J Cancer. 2000 Dec 1;88(5):778-82. doi: 10.1002/1097-0215(20001201)88:5<778::aid-ijc15>3.0.co;2-n. Int J Cancer. 2000. PMID: 11072248
Rapid detection of BRCA1 mutations by the protein truncation test.
Hogervorst FB, Cornelis RS, Bout M, van Vliet M, Oosterwijk JC, Olmer R, Bakker B, Klijn JG, Vasen HF, Meijers-Heijboer H, et al. Hogervorst FB, et al. Among authors: vasen hf. Nat Genet. 1995 Jun;10(2):208-12. doi: 10.1038/ng0695-208. Nat Genet. 1995. PMID: 7663517
Breast and ovarian cancer risks in a large series of clinically ascertained families with a high proportion of BRCA1 and BRCA2 Dutch founder mutations.
Brohet RM, Velthuizen ME, Hogervorst FB, Meijers-Heijboer HE, Seynaeve C, Collée MJ, Verhoef S, Ausems MG, Hoogerbrugge N, van Asperen CJ, Gómez García E, Menko F, Oosterwijk JC, Devilee P, van't Veer LJ, van Leeuwen FE, Easton DF, Rookus MA, Antoniou AC; HEBON Resource. Brohet RM, et al. J Med Genet. 2014 Feb;51(2):98-107. doi: 10.1136/jmedgenet-2013-101974. Epub 2013 Nov 27. J Med Genet. 2014. PMID: 24285858
386 results